PKI - PerkinElmer says Q4 results will meet or exceed prior guidance
- PerkinElmer ( NYSE: PKI ) said that it expects its Q4 2022 results to meet or exceed guidance given in November.
- Back then, the life sciences company projected pro forma total revenue is $1.06B-$1.07B vs. consensus of $1.07B and pro forma adjusted earnings per share of $1.65-$1.67 vs. consensus of $1.67.
- PerkinElmer ( PKI ) reports Q4 before market open on Feb. 14.
- Read why Heavy Moat Investments considers PerkinElmer ( PKI ) a buy.
For further details see:
PerkinElmer says Q4 results will meet or exceed prior guidance